Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...

Kirkland-based heart care company Cardiac Dimensions on Thursday raised a $53 million Series E round.

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Memorial Health System’s Department of Cardiology marked a major milestone in heart-healthy care, celebrating its 100th ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...

Memorial Health System’s Department of Cardiology celebrated its 100th transcatheter aortic valve replacement procedure, performed by Dr. Jason Schott, interventional cardiologist, and Dr. Geoffrey R.

DurAVR ® THV demonstrated a favorable hemodynamic profile sustained to one-year, with an Effective Orifice Area (EOA) of 2.1 + 0.2 cm 2, a Mean Pressure Gradient (MPG) of 8.6 + 2.6 mmHg and Doppler ...

AIIMS performed the first-ever government-sector Transcatheter Aortic Valve Implantation (TAVI) in Madhya Pradesh. This ...